NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients

NCT04337255

Active Not RecruitingNA

Sponsor: Rush University Medical Center

Conditions: Cognitive Decline, Dementia, Vascular, Alzheimer Disease, Dementia, Stroke

Interventions: Behavioral Dietary intervention ( MIND Diet), Behavioral Usual Care Diet Intervention

Countries: United States

To test the effects of a 2- to 3-year intervention of the MIND diet versus usual post-stroke care on cognitive decline, the characteristic feature of dementia, and on brain biomarkers of Alzheimer's Disease (AD) and vascular disease in a Phase Ill randomized controlled trial of 250 patients hospitalized for acute ischemic stroke, aged 55 years or older, and without dementia who are discharged home following hospitalization.

Eligibility overview

Sex: ALL

Age: 55 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
* Inclusion Criteria
* Men and women, 55 years of age - inclusive- or older
* Acute stroke as defined by an acute focal neurological deficit in combination with one of the following: acute ischemic infarct (stroke) as documented by either a DWl positive lesion on MR imaging or a new lesion on a delayed CT scan
* Written informed consent by patient prior to study participation
* Willingness to complete all assessments and participate in follow-up
* Willing to participate and give informed consent
* Adequate Visual and auditory acuity to undergo neuropsychological testing
* Exclusion criteria
* CDR\>=0.5
* Nuts, berries, olive oil, or fish allergies
* Use of medications to treat Alzheimer's disease or Parkinson's disease
* Aphasia
* Conditions of psychosis or bipolar disorder judged by study investigators to potentially interfere with study compliance over 3 years
* Report of alcohol or substance abuse within six months, or heavy alcohol consumption (\>2 drinks/d women; \>3 drinks/d men)
* Unstable or recent onset of cardiovascular disease, such as myocardial infarction within six months or presence of congestive heart failure (Stages II-IV)
* Cancer treatment \<= 5 years except non-melanoma skin cancer , basal cell skin cancer (this criterion may be waived at the site PI's discretion)
* Illness that might be associated with weight change, such as a history of stomach or gastrointestinal conditions (Inflammatory Bowel Disease, Crohn's Disease, malabsorption, colostomy, bowel resection, gastric bypass surgery, etc.)
* History of liver disease, HIV or Hepatitis C
* An intracerebral hemorrhage as documented on CT or MRI
* Pre- hospitalization diagnosis of dementia or mild cognitive impairment
* Patients presenting one of the following diseases: cerebral venous thrombosis, traumatic cerebral hemorrhage, intracerebral hemorrhage because of a known or image-guided assumed vascular malformation, pure meningeal or intraventricular hemorrhage
* Patients presenting a malignant disease with life expectancy \< 3 years
* Residence in a nursing home and thus going back to nursing home upon discharge
* Participation in an ongoing investigational drug study
* Exception to these guidelines will be rare but may be considered on a case by case basis at the discretion of the PI's
Locations (1)
  • Chicago, Illinois, United States